Generic Delay Tactics Evolving In Wake Of Consent Decrees – Initial FTC Data
This article was originally published in The Tan Sheet
Executive Summary
Potentially anticompetitive strategies on generics have evolved since the Federal Trade Commission began imposing consent agreements on companies that made questionable settlements, FTC states